Efficacy of high therapeutic doses of iodine-131 in patients with differentiated thyroid cancer and detectable serum thyroglobulin

European Journal of Nuclear Medicine

Volumn 28, Issue 2, 2001, Pages 198-202

  De Keizer, Bart ^a   Koppeschaar, Hans P F ^a   Zelissen, Pierre M J ^a   Lips, Cees J M ^a   Van Rijk, Peter P ^a   Van Dijk, Aalt ^a   De Klerk, John M H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

"Blind" therapeutic dose; Differentiated thyroid carcinoma; Radio iodine 131; Serum thyroglobulin

Indexed keywords

IODINE 131; LEVOTHYROXINE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; FEMALE; HORMONAL THERAPY; HUMAN; MALE; METASTASIS; RADIATION DOSE; RADIOSURGERY; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; THYROID SCINTISCANNING; THYROIDECTOMY;

ADULT; AGED; CARCINOMA, PAPILLARY, FOLLICULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; THYROGLOBULIN; THYROID NEOPLASMS; THYROIDECTOMY; THYROXINE; WHOLE-BODY COUNTING;

EID: 0035117813     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000443     Document Type: Article

References (23)

1. Papillary thyroid carcinoma: The impact of therapy in 576 patients
2. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer
3. Papillary and follicular thyroid carcinoma
4. Pure follicular thyroid carcinoma: Impact of therapy in 214 patients
5. Radioiodine therapy of differentiated thyroid carcinoma
6. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer
7. Thyroglobulin measurement. Techniques, clinical benefits and pitfalls
8. Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid cancer
9. Serum and tissue thyroglobulin measurement: Clinical applications in thyroid disease
10. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differential thyroid cancer in high- and low-risk patients
11. Serum thyroglobulin in the follow-up of patients with treated differentiated thyroid cancer
12. Surveillance of patients to detect recurrent thyroid carcinoma
13. Therapeutic doses of iodine-131 reveal undiagnosed metastases in thyroid cancer patients with detectable serum thyroglobulin levels
14. The effect of a low-iodine-diet on I-131 therapy in follicular thyroid carcinoma
15. Editorial: Treating high thyroglobulin with radioiodine: A magic bullet or a shot in the dark?
16. Evaluation and treatment of persistent thyroglobulinaemia in patients with well-differentiated thyroid cancer
17. Iodine-131 therapy for thyroid cancer patients with elevated thyroglobulin and negative diagnostic scan
18. Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic negative metastases: Including comments on the role of serum thyroglobulin monitoring in tumor surveillance
19. Fluorine-18-fluorodeoxyglucose dual-head positron emission tomography in the detection of recurrent differentiated thyroid cancer: Preliminary results
20. Fluorine-18-FDG and iodine-131-iodide utake in thyroid cancer
21. Intermediate and long-term side effects of high dose radioiodine therapy for thyroid carcinoma
22. The long-term hazards of the treatment of thyroid cancer with radioiodine
23. Cancer risks in thyroid cancer patients